NCT01795313 2026-02-05
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
University of Pittsburgh
Phase 1 Terminated
Clinical Trials
7 trialsNCT04809662 2024-11-07
Comparing Immune Responses to Topical Imiquimod
University of California, Davis
Terminated
NCT03982004 2021-06-21
Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Washington University School of Medicine
Phase 1 Terminated
NCT02224599 2020-04-24
Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies
Kiromic BioPharma Inc.
Phase 1/2 Terminated
NCT00979550 2018-03-22
The Effects of Aldara as an Adjunct to Laser Treatment
University of Kentucky
Phase 2 Terminated
NCT01538901 2017-09-12
AKtransplant
Medical University of Vienna
Phase 4 Terminated
NCT01203878 2014-12-08
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Tennessee Clinical Research Center
Phase 4 Terminated